<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0155">
 <element-citation publication-type="journal" id="rf0155">
  <person-group person-group-type="author">
   <name>
    <surname>Bogomolov</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Alexandrov</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Voronkova</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Macievich</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Kokina</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Petrachenkova</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Lehr</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Lempp</surname>
    <given-names>F.A.</given-names>
   </name>
   <name>
    <surname>Wedemeyer</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Haag</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Schwab</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Haefeli</surname>
    <given-names>W.E.</given-names>
   </name>
   <name>
    <surname>Blank</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Urban</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study</article-title>
  <source>J. Hepatol.</source>
  <volume>65</volume>
  <issue>3</issue>
  <year>2016</year>
  <fpage>490</fpage>
  <lpage>498</lpage>
  <pub-id pub-id-type="pmid">27132170</pub-id>
 </element-citation>
</ref>
